skip to main content
Idioma:
Tipo de recurso Mostra resultados com: Mostra resultados com: Índice

Update on 2-year outcomes of the TOMS™ transobturator male sling for the treatment of male stress urinary incontinence

Yiou, Rene ; Bütow, Zentia ; Parisot, Juliette ; Lingombet, Odile ; Augustin, Déborah ; de la Taille, Alexandre ; Salomon, Laurent ; Audureau, Etienne

Neurourology and urodynamics, 2016-01, Vol.35 (1), p.44-47 [Periódico revisado por pares]

United States: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
  • Título:
    Update on 2-year outcomes of the TOMS™ transobturator male sling for the treatment of male stress urinary incontinence
  • Autor: Yiou, Rene ; Bütow, Zentia ; Parisot, Juliette ; Lingombet, Odile ; Augustin, Déborah ; de la Taille, Alexandre ; Salomon, Laurent ; Audureau, Etienne
  • Assuntos: Aged ; Aged, 80 and over ; Follow-Up Studies ; Humans ; Male ; male sling ; Middle Aged ; overactive bladder ; Prospective Studies ; Prostatectomy - adverse effects ; radical prostatectomy ; Reoperation ; Suburethral Slings ; Treatment Outcome ; urinary incontinence ; Urinary Incontinence, Stress - etiology ; Urinary Incontinence, Stress - surgery
  • É parte de: Neurourology and urodynamics, 2016-01, Vol.35 (1), p.44-47
  • Notas: ArticleID:NAU22668
    ark:/67375/WNG-KCBP9PWX-H
    istex:20852A11F03AE9F84949E48544C8F0C75F4EC139
    ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: Aims To update the 2‐year outcomes of the TOMS™ transobturator male sling for treating post‐prostatectomy urinary incontinence (pRP‐UI) in a group of patients previously evaluated at 1 year. Methods We prospectively followed 40 patients with pRP‐UI before and 6, 12, and 24 months after implantation of the TOMS™ transobturator male sling. Urinary symptoms were evaluated using the following questionnaires: USP, ICIQ, UCLA‐PCI (urinary bother domain), PGI‐I, and daily pad use. Success was defined as patients wearing no or only one security pad. We also report on any other surgical procedures for treating persistent incontinence during the follow‐up period. Results Of 40 patients included in the 1‐year follow‐up, seven required additional surgical treatment. In the remaining patients (n = 33), significant improvement (P < 0.001) compared to baseline was seen, and a subsequent tendency (non‐significant) toward impairment was noted throughout the three postoperative follow‐ups for the ICIQ (14.4 ± 4.4 [baseline], 7.6 ± 5.7 [6 months], 8.1 ± 5.6 [12 months], 8.9 ± 5.5 [24 months]), USP‐stress urinary (6.7 ± 2.2, 2.8 ± 2.4, 2.8 ± 2.4, 3.2 ± 2.8), ULCA‐PCI‐urinary bother (10.0 ± 12.5, 66.0 ± 33.0, 64.0 ± 31.5, 62.0 ± 30.7) scores, and pad use (2.5 ± 1.2, 0.7 ± 1.1, 0.8 ± 1.2, 0.9 ± 1.2). Significant impairment in postoperative PGI‐I (6.2 ± 0.9, 6.1 ± 0.9, 5.8 ± 1.1, P = 0.028) and USP‐overactive bladder symptoms scores (5.4 ± 3.6 [6 months] vs. 6.6 ± 3.7 [24 months], P = 0.046) were noted. A total of 18 (54.5%), 17 (51.5%), and 15 (45.5%) patients wore no postoperative pad, respectively. Conclusion Approximately half of the patients continue to wear no pad 2 years after TOMS™ transobturator male sling implantation. However, a tendency toward impaired continence, possibly associated with overactive bladder symptoms, was noted. Neurourol. Urodynam. 35:44–47, 2016. © 2014 Wiley Periodicals, Inc.
  • Editor: United States: Blackwell Publishing Ltd
  • Idioma: Inglês
Links
Voltar para lista de resultados
Ir para página anteriorAnterior Resultado  10 AvançarIr para próxima página

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.